Hellstrom PM, Hein J, Bytzer P, Bjornsson E, Kristensen J, Schambye H (2009) Clinical trial: the glucagon-like peptide-1 analogue ROSE-010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo-controlled, double-blind study
GLP-1 plays a key role in regulating appetite and glucose metabolism
Early studies look promising
Moreover, ipamorelins specificity for GH release, akin to growth hormone-releasing hormone (GHRH), makes it a promising candidate for clinical development
Androgen receptor activation in glioblastoma can be achieved by ligand-independent signaling through EGFR a potential therapeutic target
Since Zepbound was approved for weight loss in late 2023, it appeared to have an advantage over Wegovy